HAART Chart - Approved Antiretroviral Drugs
From the Winter 2007 edition of the Bulletin of Experimental Treatments for AIDS
| Generic (Common) Name |
Brand Name |
Company |
Year Approved |
| Protease Inhibitors (PIs) |
| amprenavir |
Agenerase |
GlaxoSmithKline |
1999; discontinued 2004 |
| atazanavir |
Reyataz |
Bristol-Myers Squibb |
2003 |
| darunavir (TMC114) |
Prezista |
Tibotec |
2006 |
| fosamprenavir |
Lexiva (U.S.); Telzir (Europe) |
GlaxoSmithKline |
2003 |
| indinavir |
Crixivan |
Merck |
1996 |
| lopinavir/ritonavir |
Kaletra |
Abbott |
2000; Meltrex formulation 2005 |
| nelfinavir |
Viracept |
Pfizer |
1997 |
| ritonavir |
Norvir |
Abbott |
1996 |
| saquinavir |
Invirase (hard-gel)
Fortovase (soft-gel) |
Roche |
1995
1997; withdrawn 2005 |
| tipranavir |
Aptivus |
Boehringer Ingelheim |
2005 |
| Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (NRTIs) |
| abacavir |
Ziagen |
GlaxoSmithKline |
1998 |
| didanosine (ddI) |
Videx |
Bristol-Myers Squibb |
1989; extended release Videx EC 2000 |
| emtricitabine (FTC) |
Emtriva |
Gilead |
2003 |
| lamivudine (3TC) |
Epivir |
GlaxoSmithKline |
1995 |
| stavudine (d4T) |
Zerit |
Bristol-Myers Squibb |
1994 |
| tenofovir DF |
Viread |
Gilead |
2002 |
| zalcitabine (ddC) |
Hivid |
Roche |
1992; withdrawn 2005 |
| zidovudine (AZT) |
Retrovir |
GlaxoSmithKline |
1987 |
| Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) |
| delavirdine |
Rescriptor |
Pfizer |
1997 |
| efavirenz |
Sustiva (U.S.); Stocrin (elsewhere) |
Bristol-Myers Squibb |
1998 |
| nevirapine |
Viramune |
Boehringer Ingelheim |
1996 |
| Entry/Fusion Inhibitors |
| enfuvirtide (T-20) |
Fuzeon |
Trimeris |
2003 |
| Fixed-Dose Combinations |
| lamivudine/abacavir (NRTI) |
Epzicom (U.S.); Kivexa (Europe) |
GlaxoSmithKline |
2004 |
| tenofovir/emtricitabine (NRTI) |
Truvada |
Gilead |
2004 |
tenofovir/emtricitabine/
efavirenz (NRTI/NNRTI) |
Atripla |
Gilead/Bristol-Myers Squibb |
2006 |
| zidovudine/lamivudine (NRTI) |
Combivir |
GlaxoSmithKline |
1997 |
| zidovudine/lamivudine/abacavir (NRTI) |
Trizivir |
GlaxoSmithKline |
2000 |
Page last updated: 1/1/2007